Epidemiologic Survey of Lower Urinary Tract Symptoms in Asia and Australia Using the International Prostate Symptom Score

Homma, Yukio; Kawabe, Kazuki; Tsukamoto, Taiji; Yamanaka, Hidetoshi; Okada, Kiyoki; Okajima, Eigoro; Yoshida, Osamu; Kumazawa, Joichi; Gu, Fangyi; Lee, Chongwook; Hsu, Te-Chin; Cruz, Reynaldo C dela; Tantiwang, Anupan; Lim, Peter Hc; Sheikh, Masood Ahmed; Bapat, Sharad; Marshall, Villis R.; Tajima, Kazuo; Aso, Yoshio

doi:10.1111/j.1442-2042.1997.tb00138.x

Cited by 109 publications

(85 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In an international study of 7588 Asian men, 18, 29, 40 and 56% of men in their 40s, 50s, 60s and 70s, respectively, have moderate-to-severe symptoms. 53 These results are similar to those reported in Europe, North America and in studies done under less stringent conditions. 54,55 Even though differences may arise in the absolute number of individuals with moderate-to-severe symptoms in each study, there is an obvious trend toward higher symptom scores as a patient ages in all reported studies.…”

Section: Symptom Scoresupporting

confidence: 89%

Voiding dysfunction in men: pathophysiology and risk factors

Scofield

Kaplan

2008

Int J Impot Res

View full text Add to dashboard Cite

Section: Symptom Scoresupporting

confidence: 89%

Voiding dysfunction in men: pathophysiology and risk factors

Scofield

Kaplan

2008

Int J Impot Res

View full text Add to dashboard Cite

“…The high prevalence of LUTS in Malaysia is consistent with the findings in many other countries, and it increases with age from 13 to 56% for the age groups 40-49 years to .70 years respectively. [47][48][49] The high prevalence of ED in Malaysia is also consistent with rates reported across the world; prevalence of ED ranges from 15 to 54% for men above 40 years of age. 11,42 Despite the high prevalence and substantial impact of LUTS and ED on men's quality of life, 9 many men still do not seek treatment.…”

Section: Men's Health Status In Malaysiasupporting

confidence: 69%

Profile of men's health in Malaysia: problems and challenges

Tong

Low

2011

Asian J Androl

View full text Add to dashboard Cite

Men's health concerns have evolved from the traditional andrology and male sexual health to a more holistic approach that encompasses male psychological, social and physical health. The poor state of health in men compared to their female counterparts is well documented. A review of the epidemiological data from Malaysia noted a similar trend in which men die at higher rates in under 1 and above 15 years old groups and most disease categories compared to women. In Malaysia, the main causes of death in men are non-communicable diseases and injuries. Risk factors, such as risk-taking behaviour, smoking and hypertension, are prevalent and amenable to early interventions. Erectile dysfunction, premature ejaculation and prostate disorders are also prevalent. However, many of these morbidities go unreported and are not diagnosed early; therefore, opportunities for early intervention are missed. This reflects poor health knowledge and inadequate health-care utilisation among Malaysian men. Their health-seeking behaviour has been shown to be strongly influenced by family members and friends. However, more research is needed to identify men's unmet health-care needs and to develop optimal strategies for addressing them. Because the Malaysian population is aging and there is an increase in sedentary lifestyles, optimizing men's health will remain a challenge unless effective measures are implemented. The existing male-unfriendly health-care system and the negative influence of masculinity on men's health behaviour must be addressed. A national men's health policy based on a male-friendly approach to health-care delivery is urgently needed to provide a framework for addressing these challenges. Asian Journal of Andrology (2011) 13, 526-533; doi:10.1038/aja.2010.125; published online 28 February 2011Keywords: aging male; cause of death; epidemiology; health promotion; Malaysia; men's health; non-communicable diseases; risk factors INTRODUCTION Men's health has been recognized as a significant health issue in the world since the late twentieth century.1,2 Increasingly, men's health has evolved to encompass their psychological and social well-being in addition to sexual and urological health. The trigger of such changes is the acknowledgement of the discrepancy in life expectancy between men and women. The life expectancy for men at birth is shorter than that for women by an average of 4 to 6 years in almost every country in the world.3,4 It has also been documented that the differences in life expectancy are unlikely to be due solely to the biological differences between the sexes but are largely a result of the complex interaction between men and their sociocultural influences. [5][6][7] Many of the causes of death in men are attributed to their lifestyles and unhealthful behaviour, such as risk-taking behaviour, poor health-care utilisation, smoking, alcohol and obesity. 7,8 On the other hand, sexual health is also gaining attention due to its impact on men's quality of life 9 and close links to cardiovascular risk factors...

show abstract

“…3 In the United States, the prevalence of Caucasian men aged 50-79 years who were expected to meet the criteria for seeking treatment options for BPH was 6.5 out of 27 million (24%) in 2000. 4 BPH is not only prevalent in the United State 5 and Europe, [6][7][8][9][10][11] but is becoming increasingly common in Asian, 12 including Japan, 13 Korea, 14 Mainland China 15 and Hong Kong region. 16 A recent trend has emerged among BPH patients towards medical treatment, such as alpha blockers (AABs) and 5-alpha reductase inhibitors (5ARIs), over the former gold standard surgical procedure.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials

Ho¹,

Lin²,

Lui³

et al. 2013

Asian J Androl

View full text Add to dashboard Cite

Chinese herbal medicine is commonly used as a treatment for benign prostatic hyperplasia (BPH), but its efficacy and safety remain to be examined. To compare the efficacy and adverse events of Chinese herbal medicine alone or used adjuvantly with Western medications for BPH. Two independent reviewers searched the major electronic databases for randomized controlled trials comparing Chinese herbal medicine, either in single or adjuvant use with Western medication, with placebo or Western medication. Relevant journals and grey literature were also hand-searched. The outcome measures included changes in urological symptoms, urodynamic measures, prostate volume and adverse events. The frequency of commonly used herbs was also identified. Out of 13 922 identified citations of publications, 31 studies were included. Eleven studies with a Jadad score o3 were selected for meta-analysis. Chinese herbal medicine was superior to Western medication in improving quality of life and reducing prostate volume. The frequency of adverse events in Chinese herbal medicine was similar to that of placebo and less than that of Western medication. The evidence is too weak to support the efficacy of Chinese herbal medicine for BPH due to the poor methodological quality and small number of trials included. The commonly used herbs identified here should provide insights for future clinical practice and research. Larger randomized controlled trials of better quality are needed to truly evaluate the efficacy of Chinese herbal medicine.

show abstract

Epidemiologic Survey of Lower Urinary Tract Symptoms in Asia and Australia Using the International Prostate Symptom Score

Cited by 109 publications

References 18 publications

Voiding dysfunction in men: pathophysiology and risk factors

Voiding dysfunction in men: pathophysiology and risk factors

Profile of men's health in Malaysia: problems and challenges

Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials

Contact Info

Product

Resources

About